» Articles » PMID: 27354785

Impact of Mild Exacerbation on COPD Symptoms in a Japanese Cohort

Overview
Publisher Dove Medical Press
Specialty Pulmonary Medicine
Date 2016 Jun 30
PMID 27354785
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with COPD might not report mild exacerbation. The frequency, risk factors, and impact of mild exacerbation on COPD status are unknown.

Objectives: The present study was performed to compare features between mild exacerbation and moderate or severe exacerbation in Japanese patients with COPD.

Patients And Methods: An observational COPD cohort was designed at Keio University and affiliated hospitals to prospectively investigate the management of COPD comorbidities. This study analyzes data only from patients with COPD who had completed annual examinations and questionnaires over a period of 2 years (n=311).

Results: Among 59 patients with mild exacerbations during the first year, 32.2% also experienced only mild exacerbations in the second year. Among 60 patients with moderate or severe exacerbations during the first year, 40% also had the same severity of exacerbation during the second year. Findings of the COPD assessment test and the symptom component of the St George's Respiratory Questionnaire at steady state were worse in patients with mild exacerbations than in those who were exacerbation free during the 2-year study period, although the severity of the ratio of predicted forced expiratory volume in 1 second did not differ between them. Severe airflow limitation (the ratio of predicted forced expiratory volume in 1 second <50%) and experience of mild exacerbations independently advanced the likelihood of an elevated COPD assessment test score to ≥2 per year.

Conclusion: The severity of COPD exacerbation seemed to be temporally stable over 2 years, and even mild exacerbations adversely impacted the health-related quality of life of patients with COPD.

Citing Articles

Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.

Rhee C, Choi J, Park Y, Yoo K J Korean Med Sci. 2024; 39(19):e164.

PMID: 38769923 PMC: 11106559. DOI: 10.3346/jkms.2024.39.e164.


Breathlessness and "exacerbation" questions predictive for incident COPD (MARKO study): data after two years of follow-up.

Vrbica Z, Steiner J, Labor M, Gudelj I, Plavec D PeerJ. 2023; 11:e16650.

PMID: 38130928 PMC: 10734450. DOI: 10.7717/peerj.16650.


Interaction of BMI and respiratory status in obstructive sleep apnea, a cross-sectional COPD study.

Haraguchi Hashiguchi M, Chubachi S, Yamasawa W, Otsuka K, Harada N, Miyao N NPJ Prim Care Respir Med. 2023; 33(1):30.

PMID: 37582926 PMC: 10427682. DOI: 10.1038/s41533-023-00351-w.


Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease.

Bhatt S, Agusti A, Bafadhel M, Christenson S, Bon J, Donaldson G Am J Respir Crit Care Med. 2023; 208(10):1026-1041.

PMID: 37560988 PMC: 10867924. DOI: 10.1164/rccm.202209-1748SO.


Bacterial Species and Inflammatory Cell Variability in Respiratory Tracts of Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A Multicentric Study.

Salama K, Moazen E, Elsawy S, Kotb S, Mohammed E, Tahoun S Infect Drug Resist. 2023; 16:2107-2115.

PMID: 37070124 PMC: 10105586. DOI: 10.2147/IDR.S402828.


References
1.
Tanabe N, Muro S, Hirai T, Oguma T, Terada K, Marumo S . Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011; 183(12):1653-9. DOI: 10.1164/rccm.201009-1535OC. View

2.
Kon S, Canavan J, Jones S, M Nolan C, Clark A, Dickson M . Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014; 2(3):195-203. DOI: 10.1016/S2213-2600(14)70001-3. View

3.
Martinez C, Okajima Y, Murray S, Washko G, Martinez F, Silverman E . Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res. 2014; 15:62. PMC: 4049804. DOI: 10.1186/1465-9921-15-62. View

4.
Seemungal T, Donaldson G, Bhowmik A, Jeffries D, Wedzicha J . Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 161(5):1608-13. DOI: 10.1164/ajrccm.161.5.9908022. View

5.
Miyazaki M, Nakamura H, Chubachi S, Sasaki M, Haraguchi M, Yoshida S . Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014; 15:13. PMC: 3922022. DOI: 10.1186/1465-9921-15-13. View